860129 | C18:0-d7 Fuc-GM1 Ceramide (d18:1/18:0-d7), synthetic
C18:0-d7 Fuc-GM1 Ganglioside ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4Glcb-Ceramide(d18:1/18:0-d7))

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C18:0-d7 Fuc-GM1 Ceramide (d18:1/18:0-d7), synthetic
C18:0-d7 Fuc-GM1 Ganglioside ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4Glcb-Ceramide(d18:1/18:0-d7))
C18:0 Fuc-GM1 Ceramide (d18:1/18:0) is a ganglioside that is a tumor associated antigen expressed in large amounts in patients with small cell lung cancer, but is completely absent in normal lung cells. This makes this ganglioside a promising target for immuno-oncology.
C79H134D7N3O35
CAS Registry Number is a Registered Trademark of the American Chemical Society
- Certificate of Analysis (Lot No. 860129W-100UG-A-010 and 7201WDA010)